BR112021020241A2 - Derivados de heteroarila bicíclica como inibidores de ectonucleotídeo pirofosfatase fosfodiesterase 1 - Google Patents

Derivados de heteroarila bicíclica como inibidores de ectonucleotídeo pirofosfatase fosfodiesterase 1

Info

Publication number
BR112021020241A2
BR112021020241A2 BR112021020241A BR112021020241A BR112021020241A2 BR 112021020241 A2 BR112021020241 A2 BR 112021020241A2 BR 112021020241 A BR112021020241 A BR 112021020241A BR 112021020241 A BR112021020241 A BR 112021020241A BR 112021020241 A2 BR112021020241 A2 BR 112021020241A2
Authority
BR
Brazil
Prior art keywords
bicyclic heteroaryl
inhibitors
ectonucleotide pyrophosphatase
heteroaryl derivatives
phosphodiesterase
Prior art date
Application number
BR112021020241A
Other languages
English (en)
Inventor
Klaus Klumpp
Ronald Hawley
Original Assignee
Riboscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riboscience Llc filed Critical Riboscience Llc
Publication of BR112021020241A2 publication Critical patent/BR112021020241A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C07F9/65038—Five-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

a presente invenção refere-se a certos compostos de heteroarila bicíclica que inibem a atividade enzimática de ectonucleotídeo pirofosfatase/fosfodiesterase 1 (enpp1) e são, portanto, úteis para o tratamento de doenças e afecções moduladas, pelo menos em parte, por enpp1. em algumas modalidades, os compostos de heteroarila bicíclica incluem aqueles de fórmula (i). são também fornecidas no presente documento composições farmacêuticas contendo tais compostos e processos para preparar tais compostos. (i)
BR112021020241A 2019-04-12 2020-04-10 Derivados de heteroarila bicíclica como inibidores de ectonucleotídeo pirofosfatase fosfodiesterase 1 BR112021020241A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962833455P 2019-04-12 2019-04-12
US201962881111P 2019-07-31 2019-07-31
PCT/US2020/027700 WO2020210649A1 (en) 2019-04-12 2020-04-10 Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors

Publications (1)

Publication Number Publication Date
BR112021020241A2 true BR112021020241A2 (pt) 2021-12-07

Family

ID=70465561

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021020241A BR112021020241A2 (pt) 2019-04-12 2020-04-10 Derivados de heteroarila bicíclica como inibidores de ectonucleotídeo pirofosfatase fosfodiesterase 1

Country Status (22)

Country Link
EP (2) EP3952995B1 (pt)
JP (1) JP2022526432A (pt)
KR (1) KR20210151873A (pt)
CN (1) CN114040915A (pt)
AU (1) AU2020272034A1 (pt)
BR (1) BR112021020241A2 (pt)
CA (1) CA3136443A1 (pt)
DK (1) DK3952995T3 (pt)
ES (1) ES2960987T3 (pt)
FI (1) FI3952995T3 (pt)
HR (1) HRP20231413T1 (pt)
HU (1) HUE064377T2 (pt)
IL (1) IL286966A (pt)
LT (1) LT3952995T (pt)
MX (2) MX2021012305A (pt)
PL (1) PL3952995T3 (pt)
PT (1) PT3952995T (pt)
RS (1) RS64792B1 (pt)
SG (1) SG11202110888QA (pt)
SI (1) SI3952995T1 (pt)
TW (1) TW202103708A (pt)
WO (1) WO2020210649A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023008761A (es) * 2021-01-29 2023-08-22 Txinno Bioscience Inc Derivado de benzotriazol novedoso que posee actividad inhibitoria contra la ectonucleotido pirofosfatasa - fosfodiesterasa y uso del mismo.
US20240209005A1 (en) * 2021-03-16 2024-06-27 Riboscience Llc Bicyclic heteroaryl boronate derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors
CN116444544A (zh) * 2022-01-10 2023-07-18 中国科学院上海药物研究所 苯并咪唑类化合物及其医药用途
US20240208997A1 (en) * 2022-11-09 2024-06-27 Boehringer Ingelheim International Gmbh Cyclic benzimidazole derivatives as cgas inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
EP1885714B1 (en) * 2005-05-24 2014-01-15 LEK Pharmaceuticals d.d. Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl)methyl)-imidazole, dihydroimidazole or benzimidazole derivatives
CN100427488C (zh) * 2005-10-21 2008-10-22 上海东升新材料有限公司 腺嘌呤类衍生物及其合成方法
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP3246034A1 (en) * 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
SI2558577T1 (sl) * 2010-04-16 2019-05-31 Nuevolution A/S Bifunkcionalni kompleksi in metode za pripravo in uporabo takšnih kompleksov
MX2013013331A (es) * 2011-05-17 2014-10-17 Principia Biopharma Inc Derivados de azaindol como inhibidores de tirosina-cinasas.
WO2016055582A1 (en) 2014-10-08 2016-04-14 Thomas Helledays Stiftelse För Medicinsk Forskning Heterocyclic compounds as dctpp1 modulators
UA121775C2 (uk) * 2015-07-31 2020-07-27 Пфайзер Інк. 1,1,1-трифтор-3-гідроксипропан-2-ілкарбаматні похідні та 1,1,1-трифтор-4-гідроксибутан-2-ілкарбаматні похідні як інгібітори magl
BR112019012618A2 (pt) * 2016-12-22 2019-11-26 Mavupharma Inc inibidores de fosfodiesterase e métodos de tratamento microbiano
JP2020504745A (ja) * 2016-12-22 2020-02-13 マブファーマ，インク． Ｉ型ｉｆｎ産生を増強または増大する組成物および方法
US10487084B2 (en) * 2017-08-16 2019-11-26 Bristol-Myers Squibb Company Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
WO2019096113A1 (zh) * 2017-11-14 2019-05-23 深圳市塔吉瑞生物医药有限公司 一种氘代的含硼的化合物及药物组合物和用途

Also Published As

Publication number Publication date
HUE064377T2 (hu) 2024-03-28
LT3952995T (lt) 2023-11-10
ES2960987T3 (es) 2024-03-07
CA3136443A1 (en) 2020-10-15
AU2020272034A1 (en) 2021-10-28
CN114040915A (zh) 2022-02-11
WO2020210649A1 (en) 2020-10-15
RS64792B1 (sr) 2023-11-30
SG11202110888QA (en) 2021-10-28
TW202103708A (zh) 2021-02-01
EP3952995B1 (en) 2023-09-20
FI3952995T3 (fi) 2023-10-26
KR20210151873A (ko) 2021-12-14
PT3952995T (pt) 2023-10-25
HRP20231413T1 (hr) 2024-02-16
SI3952995T1 (sl) 2023-12-29
DK3952995T3 (da) 2023-10-30
MX2021012305A (es) 2021-11-12
EP3952995A1 (en) 2022-02-16
MX2023011065A (es) 2023-09-28
IL286966A (en) 2021-12-01
PL3952995T3 (pl) 2024-03-11
JP2022526432A (ja) 2022-05-24
EP4249070A2 (en) 2023-09-27
EP4249070A3 (en) 2024-04-17
US20220362266A1 (en) 2022-11-17

Similar Documents

Publication Publication Date Title
BR112021020241A2 (pt) Derivados de heteroarila bicíclica como inibidores de ectonucleotídeo pirofosfatase fosfodiesterase 1
CO2019006622A2 (es) Derivados de pirazol como inhibidores de malt1
MX2021013110A (es) Compuestos heterociclicos como inhibidores de la cinasa ret.
BR112019024830A2 (pt) inibidores de bcl6 derivados de benzimidazolona
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
BR112013003114A2 (pt) inibidores de tirosina quinase de bruton
BR112019018648A2 (pt) Inibidores de jak contendo uma amida heterocíclica com 4 membros
EP4104837A3 (en) Heterocyclic compounds as ret kinase inhibitors
BR112017020999A2 (pt) inibidores de indolamina-2,3-dioxigenase para o tratamento de câncer
CL2020001576A1 (es) Componentes heterocíclicos bicíclicos sustituidos como inhibidores de prmt5.
BR112015022462A2 (pt) inibidores de ido
BRPI0814065B8 (pt) derivados de alcoóis de 1-fenil-2-piridinil alquila como inibidores da fosfodiesterase
BR112015032664A2 (pt) composições
BR112015032595A2 (pt) inibidores de ido
BR112013026137A8 (pt) pirimidinil-pirróis substituídos ativos como inibidores da quinase
BR112015028501B8 (pt) Compostos derivados de bipirazol, seus sais, composição compreendendo o composto ou o sal, método de inibição in vitro de uma atividade de jak1, e processo de preparação de sal de ácido fosfórico
BR112013018515A2 (pt) derivados de pirrol tricíclico, processo para preparação e seu uso como inibidores da quinase
EA201990904A1 (ru) 1,3-дизамещенные производные циклобутана или азетидина в качестве ингибиторов гемопоэтической простагландин-d-синтазы
EA202190055A1 (ru) Производные пиразола в качестве ингибиторов malt1
BR112019003710A2 (pt) inibidor de pde7, composto, composição farmacêutica, uso de um inibidor de pde7 ou de um composto, e, método para tratar ou prevenir uma doença que é melhorada pela inibição de pde7.
MX2022000164A (es) Inhibidores de tirosina cinasa no receptora 1 (tnk1) y usos de los mismos.
BR112023019030A2 (pt) Derivados de fósforo como inibidores de sos1
BR112023012947A2 (pt) Inibidores de lrrk2
MX370010B (es) Inhibidores de tirosina cinasa de bruton.
MX2016006744A (es) Inhibidores de tirosina cinasa de bruton.